5′-O-Tritylated Nucleoside Derivatives: Inhibition of Thymidine Phosphorylase and Angiogenesis
Authors:
- Sandra LiekensSLSandra Liekens
- Annelies BronckaersAnnelies Bronckaers
- Ana-Isabel HernándezAHAna-Isabel Hernández
- Eva-María PriegoEPEva-María Priego
- Elena CasanovaECElena Casanova
- Maria-José CamarasaMCMaria-José Camarasa
- Maria-Jesus Pérez-PérezMaria-Jesus Pérez-Pérez
- Jan BalzariniJBJan Balzarini
Open Access
- 1 August 2006
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 70 (2) , 501-509
Abstract
Thymidine phosphorylase (TPase) is one of the key enzymes involved in the pyrimidine nucleoside salvage pathway. However, TPase also stimulates angiogenesis, and its expression correlates well with microvessel density and metastasis in a variety of human tumors. We have shown recently that 5′-O-trityl-inosine (KIN59) allosterically inhibits TPase enzymatic activity. KIN59 also inhibits TPase-induced angiogenesis in the chick chorioallantoic membrane (CAM) assay. The trityl group was found to be instrumental to preserve both the anti-TPase and antiangiogenic effect. We have now synthesized a variety of novel 5′-O-trityl nucleoside derivatives. Enzyme activity studies showed that the anti-TPase activity is significantly improved by replacement of the hypoxanthine base by thymine [3.5-fold; i.e., 5′-O-tritylthymidine (KIN6)] and the introduction of chloride on the trityl group [7-fold; i.e., 5′-O-(4-chlorotrityl)-inosine (TP136)], whereas removal of 2′-hydroxyl in the ribose did not significantly alter the anti-TPase activity. Enzyme kinetic studies also demonstrated that 1-(5′-O-trityl-β-d-ribofuranosyl)-thymine (TP124), like KIN59, inhibits TPase in a noncompetitive fashion both with respect to phosphate and thymidine. Most KIN59 analogs markedly inhibited TPase-induced angiogenesis in the CAM assay. In vitro studies showed that the antiangiogenic effect of these compounds is not attributed to endothelial cell toxicity. For several compounds, there was no stringent correlation between their anti-TPase and antiangiogenic activity, indicating that these compounds may also act on other angiogenesis mediators. The antiangiogenic 5′-O-trityl nucleoside analogs also caused degradation of pre-existing, immature vessels at the site of drug exposure. Thus, 5′-O-trityl nucleoside derivatives combine antiangiogenic and vascular-targeting activities, which opens perspectives for their potential use as anticancer agents.Keywords
This publication has 41 references indexed in Scilit:
- Antiangiogenic and Vascular-Targeting Activity of the Microtubule-Destabilizing trans-Resveratrol Derivative 3,5,4′-TrimethoxystilbeneMolecular Pharmacology, 2005
- Use of angiogenesis inhibitors in tumour treatmentEuropean Journal of Cancer, 2005
- The role of thymidine phosphorylase, an angiogenic enzyme, in tumor progressionCancer Science, 2004
- Sulfasalazine Down-Regulates the Expression of the Angiogenic Factors Platelet-Derived Endothelial Cell Growth Factor/Thymidine Phosphorylase and Interleukin-8 in Human Monocytic-Macrophage THP1 and U937 CellsMolecular Pharmacology, 2004
- Synthesis of acyclic bis-vinyl pyrimidines: a general route to d4T via metathesisTetrahedron, 2003
- Kinetic analysis of novel multisubstrate analogue inhibitors of thymidine phosphorylaseFEBS Letters, 2000
- Design, Synthesis, and Enzymatic Evaluation of Multisubstrate Analogue Inhibitors of Escherichia coli Thymidine PhosphorylaseJournal of Medicinal Chemistry, 2000
- 7‐Deazaxanthine, a novel prototype inhibitor of thymidine phosphorylaseFEBS Letters, 1998
- The chemistry of 2',3'-seconucleosides III. synthesis and reactions of purine-2',3'-secoribonucleosidesTetrahedron, 1988
- Phosphorolysis of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and other 5-substituted-2'-deoxyuridines by purified human thymidine phosphorylase and intact blood plateletsBiochemical Pharmacology, 1983